ISABELLEBEDROSIANISABELLE BEDROSIAN8959BEDROSIAN, ISABELLEProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson1400 Pressler StHouston77030-4008TXAuthorship 1635562Authorship 1681495Authorship 1715127Authorship 1717094Authorship 1735921Authorship 1736897Authorship 17409411Authorship 1742281Authorship 1754997Authorship 1756602Authorship 1773281Authorship 1775552Authorship 17839211Authorship 1788997Authorship 1841432Authorship 1849524Authorship 1903324Authorship 1908357Authorship 1913678Authorship 19158414Authorship 1919791Authorship 1926196Authorship 19515231778940Clark BD, Bedrosian I, Schindler R, Cominelli F, Cannon JG, Shaw AR, Dinarello CAJournal of applied physiology (Bethesda, Md. : 1985)Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J Appl Physiol (1985). 1991 Dec; 71(6):2412-8.J Appl Physiol (1985)1991-12-01T00:00:001991Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays.10091794Czerniecki BJ, Scheff AM, Callans LS, Spitz FR, Bedrosian I, Conant EF, Orel SG, Berlin J, Helsabeck C, Fraker DL, Reynolds CCancerImmunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer. 1999 Mar 01; 85(5):1098-103.Cancer1999-03-01T00:00:001999Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma.11888875Bauer TW, Spitz FR, Callans LS, Alavi A, Mick R, Weinstein SP, Bedrosian I, Fraker DL, Bauer TL, Czerniecki BJAnnals of surgical oncologySubareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol. 2002 Mar; 9(2):169-76.Ann Surg Oncol2002-03-01T00:00:002002Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer.12928369Xu S, Koski GK, Faries M, Bedrosian I, Mick R, Maeurer M, Cheever MA, Cohen PA, Czerniecki BJJournal of immunology (Baltimore, Md. : 1950)Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism. J Immunol. 2003 Sep 01; 171(5):2251-61.J Immunol2003-09-01T00:00:002003Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism.15968686Shen J, Hunt KK, Mirza NQ, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Ross MI, Ames FC, Feig BW, Singletary SE, Cristofanilli M, Meric-Bernstam FCancerPredictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer. 2005 Aug 01; 104(3):479-90.Cancer2005-08-01T00:00:002005Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.16978971Rosenkranz KM, Bedrosian I, Feng L, Hunt KK, Hartman K, Lucci A, Meric-Bernstam F, Kuerer HM, Singletary ES, Hwang R, Feig B, Ross M, Ames F, Babiera GVAmerican journal of surgeryBreast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center. Am J Surg. 2006 Oct; 192(4):541-4.Am J Surg2006-10-01T00:00:002006Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center.16978974Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KKAmerican journal of surgeryOutcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg. 2006 Oct; 192(4):552-5.Am J Surg2006-10-01T00:00:002006Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.18327638Lang JE, Mosalpuria K, Cristofanilli M, Krishnamurthy S, Reuben J, Singh B, Bedrosian I, Meric-Bernstam F, Lucci ABreast cancer research and treatmentHER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer. Breast Cancer Res Treat. 2009 Feb; 113(3):501-7.Breast Cancer Res Treat2008-03-09T00:00:002008HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer.20647335Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, Kuerer HM, Babiera GV, Mittendorf EA, Ready K, Litton J, Meric-Bernstam FCancer prevention research (Philadelphia, Pa.)Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila). 2010 Aug; 3(8):1026-34.Cancer Prev Res (Phila)2010-07-20T00:00:002010Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.21979111Wagner JL, Fearmonti R, Hunt KK, Hwang RF, Meric-Bernstam F, Kuerer HM, Bedrosian I, Crosby MA, Baumann DP, Ross MI, Feig BW, Krishnamurthy S, Hernandez M, Babiera GVAnnals of surgical oncologyProspective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer. Ann Surg Oncol. 2012 Apr; 19(4):1137-44.Ann Surg Oncol2011-10-07T00:00:002011Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer.22621334Caudle AS, Yu TK, Tucker SL, Bedrosian I, Litton JK, Gonzalez-Angulo AM, Hoffman K, Meric-Bernstam F, Hunt KK, Buchholz TA, Mittendorf EABreast cancer research : BCRLocal-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Res. 2012 May 23; 14(3):R83.Breast Cancer Res2012-05-23T00:00:002012Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.22622473Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HMAnnals of surgical oncologyBiology, treatment, and outcome in very young and older women with DCIS. Ann Surg Oncol. 2012 Nov; 19(12):3777-84.Ann Surg Oncol2012-05-24T00:00:002012Biology, treatment, and outcome in very young and older women with DCIS.23115888Bedrosian I, Nelson HBulletin of the American College of SurgeonsThe paradox of breast MRI: does finding occult disease make a difference? Bull Am Coll Surg. 2012 Oct; 97(10):57-9.Bull Am Coll Surg2012-10-01T00:00:002012The paradox of breast MRI: does finding occult disease make a difference?24888808Rueth NM, Lin HY, Bedrosian I, Shaitelman SF, Ueno NT, Shen Y, Babiera GJournal of clinical oncology : official journal of the American Society of Clinical OncologyUnderuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database. J Clin Oncol. 2014 Jul 01; 32(19):2018-24.J Clin Oncol2014-06-02T00:00:002014Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database.Investigational Cancer TherapeuticsRadiation OncologyMD AndersonHENRY MARKKUERERHENRY MARK KUERER8727KUERER, HENRY MARKProfessorTHOMAS ABUCHHOLZTHOMAS A BUCHHOLZ8732BUCHHOLZ, THOMAS AProfessorANJANABHARDWAJANJANA BHARDWAJ9092BHARDWAJ, ANJANAAssistant ProfessorKELLY KHUNTKELLY K HUNT8555HUNT, KELLY KProfessor6.768290.00541589533research areas5.084360.0150174131coauthor of297.22742.526460similar to11245selected publicationsELIZABETH ANNMITTENDORFELIZABETH ANN MITTENDORF9277MITTENDORF, ELIZABETH ANNAssociate ProfessorFUNDAMERIC-BERNSTAMFUNDA MERIC-BERNSTAM8778MERIC-BERNSTAM, FUNDAProfessorSIMONA F.SHAITELMANSIMONA F. SHAITELMAN9767SHAITELMAN, SIMONA F.Assistant ProfessorGILDYBABIERAGILDY BABIERA8684BABIERA, GILDYProfessorAuthorship 2121961Authorship 2175543Authorship 2182061Authorship 2187692Authorship 2188376Authorship 2188832Authorship 2188936Authorship 2193154Authorship 2195913Authorship 2204841Authorship 2204981Authorship 2241208Authorship 22481910Authorship 2249771Authorship 2250409Authorship 2265495Authorship 2272325Authorship 2273594Authorship 2279514Authorship 2286256Authorship 2287717Authorship 2294524Authorship 2299407Authorship 2303124Authorship 23042711Authorship 2306287Authorship 23238112Authorship 2328226Authorship 23351115Authorship 2341012Authorship 23482671790304Bedrosian I, Sofia RD, Wolff SM, Dinarello CACytokineTaurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. Cytokine. 1991 Nov; 3(6):568-75.Cytokine1991-11-01T00:00:001991Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells.10468608Engels FH, Koski GK, Bedrosian I, Xu S, Luger S, Nowell PC, Cohen PA, Czerniecki BJProceedings of the National Academy of Sciences of the United States of AmericaCalcium signaling induces acquisition of dendritic cell characteristics in chronic myelogenous leukemia myeloid progenitor cells. Proc Natl Acad Sci U S A. 1999 Aug 31; 96(18):10332-7.Proc Natl Acad Sci U S A1999-08-31T00:00:001999Calcium signaling induces acquisition of dendritic cell characteristics in chronic myelogenous leukemia myeloid progenitor cells.10838660Bedrosian I, Roros JG, Xu S, Nguyen HQ, Engels F, Faries MB, Koski GK, Cohen PA, Czerniecki BJJournal of immunotherapy (Hagerstown, Md. : 1997)Granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-12 synergize with calcium ionophore to enhance dendritic cell function. J Immunother. 2000 May-Jun; 23(3):311-20.J Immunother2000-05-01T00:00:002000Granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-12 synergize with calcium ionophore to enhance dendritic cell function.10996197Engels FH, Kreisel D, Faries MB, Bedrosian I, Koski GK, Cohen PA, Czerniecki BJLeukemia researchCalcium ionophore activation of chronic myelogenous leukemia progenitor cells into dendritic cells is mediated by calcineurin phosphatase. Leuk Res. 2000 Oct; 24(10):795-804.Leuk Res2000-10-01T00:00:002000Calcium ionophore activation of chronic myelogenous leukemia progenitor cells into dendritic cells is mediated by calcineurin phosphatase.11330786Czerniecki BJ, Bedrosian I, Faries M, Alavi ASeminars in nuclear medicineRevolutionary impact of lymphoscintigraphy and intraoperative sentinel node mapping in the clinical practice of oncology. Semin Nucl Med. 2001 Apr; 31(2):158-64.Semin Nucl Med2001-04-01T00:00:002001Revolutionary impact of lymphoscintigraphy and intraoperative sentinel node mapping in the clinical practice of oncology.11352421Wildemore JK, Schuchter L, Mick R, Synnestvedt M, Elenitsas R, Bedrosian I, Czerniecki BJ, Guerry D, Lessin SR, Elder DE, Bucky LPAnnals of plastic surgeryLocally recurrent malignant melanoma characteristics and outcomes: a single-institution study. Ann Plast Surg. 2001 May; 46(5):488-94.Ann Plast Surg2001-05-01T00:00:002001Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study.11588047Faries MB, Bedrosian I, Xu S, Koski G, Roros JG, Moise MA, Nguyen HQ, Engels FH, Cohen PA, Czerniecki BJBloodCalcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development. Blood. 2001 Oct 15; 98(8):2489-97.Blood2001-10-15T00:00:002001Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development.11642602Czerniecki BJ, Cohen PA, Faries M, Xu S, Roros JG, Bedrosian ICritical reviews in immunologyDiverse functional activity of CD83+ monocyte-derived dendritic cells and the implications for cancer vaccines. Crit Rev Immunol. 2001; 21(1-3):157-78.Crit Rev Immunol2001-01-01T00:00:002001Diverse functional activity of CD83+ monocyte-derived dendritic cells and the implications for cancer vaccines.12563321Keyomarsi K, Tucker SL, Bedrosian INature medicineCyclin E is a more powerful predictor of breast cancer outcome than proliferation. Nat Med. 2003 Feb; 9(2):152.Nat Med2003-02-01T00:00:002003Cyclin E is a more powerful predictor of breast cancer outcome than proliferation.12744615Bedrosian I, Gershenwald JEThe Surgical clinics of North AmericaSurgical clinical trials in melanoma. Surg Clin North Am. 2003 Apr; 83(2):385-403.Surg Clin North Am2003-04-01T00:00:002003Surgical clinical trials in melanoma.14551301Bedrosian I, Mick R, Xu S, Nisenbaum H, Faries M, Zhang P, Cohen PA, Koski G, Czerniecki BJJournal of clinical oncology : official journal of the American Society of Clinical OncologyIntranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients. J Clin Oncol. 2003 Oct 15; 21(20):3826-35.J Clin Oncol2003-10-15T00:00:002003Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients.16926572Boughey JC, Peintinger F, Meric-Bernstam F, Perry AC, Hunt KK, Babiera GV, Singletary SE, Bedrosian I, Lucci A, Buzdar AU, Pusztai L, Kuerer HMAnnals of surgeryImpact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer. Ann Surg. 2006 Sep; 244(3):464-70.Ann Surg2006-09-01T00:00:002006Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer.17699858Bedrosian I, Lee C, Tucker SL, Palla SL, Lu K, Keyomarsi KClinical cancer research : an official journal of the American Association for Cancer ResearchCyclin E-associated kinase activity predicts response to platinum-based chemotherapy. Clin Cancer Res. 2007 Aug 15; 13(16):4800-6.Clin Cancer Res2007-08-15T00:00:002007Cyclin E-associated kinase activity predicts response to platinum-based chemotherapy.17826054Boughey JC, Middleton LP, Harker L, Garrett B, Fornage B, Hunt KK, Babiera GV, Dempsey P, Bedrosian IAmerican journal of surgeryUtility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast. Am J Surg. 2007 Oct; 194(4):450-5.Am J Surg2007-10-01T00:00:002007Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast.18164831Reed VK, Cavalcanti JL, Strom EA, Perkins GH, Oh JL, Tereffe W, Yu TK, Yeung H, Whitman GJ, Bedrosian I, Macapinlac HA, Buchholz TA, Woodward WAInternational journal of radiation oncology, biology, physicsRisk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):435-40.Int J Radiat Oncol Biol Phys2007-12-31T00:00:002007Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer.18427152Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera GJournal of clinical oncology : official journal of the American Society of Clinical OncologyMammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol. 2008 May 20; 26(15):2482-8.J Clin Oncol2008-04-21T00:00:002008Mammography before diagnosis among women age 80 years and older with breast cancer.18436181Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF, Hunt KKAmerican journal of surgeryRole of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg. 2008 Jul; 196(1):81-7.Am J Surg2008-04-23T00:00:002008Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.18663571Lucci A, Krishnamurthy S, Singh B, Bedrosian I, Meric-Bernstam F, Reuben J, Broglio K, Mosalpuria K, Lodhi A, Vincent L, Cristofanilli MBreast cancer research and treatmentCyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow. Breast Cancer Res Treat. 2009 Sep; 117(1):61-8.Breast Cancer Res Treat2008-07-29T00:00:002008Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.19680729Fearmonti RM, Gayed IW, Kim E, Bedrosian I, Hunt KK, Meric-Bernstam F, Feig B, Ghonimi E, Warneke C, Babiera GVAnnals of surgical oncologyIntra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer. Ann Surg Oncol. 2010 Jan; 17(1):220-7.Ann Surg Oncol2009-08-13T00:00:002009Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer.20559739Hall C, Krishnamurthy S, Lodhi A, Mosalpuria K, Kuerer HM, Meric-Bernstam F, Bedrosian I, Hunt KK, Lucci AAnnals of surgical oncologyDisseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. Ann Surg Oncol. 2010 Dec; 17(12):3252-8.Ann Surg Oncol2010-06-18T00:00:002010Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients.20655242Van Leeuwen BL, Rosenkranz KM, Feng LL, Bedrosian I, Hartmann K, Hunt KK, Kuerer HM, Ross M, Singletary SE, Babiera GV, Department of Surgical Oncology, MD Anderson Cancer CenterCritical reviews in oncology/hematologyThe effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol Hematol. 2011 Sep; 79(3):315-20.Crit Rev Oncol Hematol2010-07-23T00:00:002010The effect of under-treatment of breast cancer in women 80 years of age and older.20853057Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L, Hunt KKAnnals of surgical oncologyTrends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:343-51.Ann Surg Oncol2010-09-19T00:00:002010Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.21147692Valero V, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EAClinical breast cancerSentinel lymph node dissection is technically feasible in older breast cancer patients. Clin Breast Cancer. 2010 Dec 01; 10(6):477-82.Clin Breast Cancer2010-12-01T00:00:002010Sentinel lymph node dissection is technically feasible in older breast cancer patients.21327455Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EAAnnals of surgical oncologyMultidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol. 2011 Sep; 18(9):2407-12.Ann Surg Oncol2011-09-01T00:00:002011Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial.21494124Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babiera GV, Kuerer HM, Hunt KK, Yang W, Sahin AA, Meric-Bernstam FAnnals of surgeryDelays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011 Jul; 254(1):119-24.Ann Surg2011-07-01T00:00:002011Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients.21691416Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes K, Meric-Bernstam F, Bedrosian I, McGahren M, Agarwal R, Zhang F, Overgaard J, Alsner J, Neve RM, Kuo WL, Gray JW, Borresen-Dale AL, Mills GBClinical proteomicsA Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers. Clin Proteomics. 2010 Dec; 6(4):129-51.Clin Proteomics2010-12-01T00:00:002010A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.22392043Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KKBreast cancer research and treatmentBiologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat. 2012 Jun; 133(3):1131-41.Breast Cancer Res Treat2012-03-04T00:00:002012Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.23122536Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KKJournal of the American College of SurgeonsImpact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population. J Am Coll Surg. 2013 Jan; 216(1):105-13.J Am Coll Surg2012-11-02T00:00:002012Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population.24077681Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, Spizzo R, Zhang X, de Weerd V, Shimizu M, Ling H, Buiga R, Pop V, Irimie A, Fodde R, Bedrosian I, Martens JW, Foekens JA, Berindan-Neagoe I, Calin GAOncotargetCCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget. 2013 Oct; 4(10):1748-62.Oncotarget2013-10-01T00:00:002013CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations.24247170Hwang ES, Bedrosian IJAMA internal medicinePatterns of breast magnetic resonance imaging use: an opportunity for data-driven resource allocation. JAMA Intern Med. 2014 Jan; 174(1):122-4.JAMA Intern Med2014-01-01T00:00:002014Patterns of breast magnetic resonance imaging use: an opportunity for data-driven resource allocation.24510381Akay CL, Ueno NT, Chisholm GB, Hortobagyi GN, Woodward WA, Alvarez RH, Bedrosian I, Kuerer HM, Hunt KK, Huo L, Babiera GVCancerPrimary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer. 2014 May 01; 120(9):1319-28.Cancer2014-02-07T00:00:002014Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.Authorship 2422711Authorship 2442601Authorship 2444301Authorship 2457131Authorship 2468394Authorship 24743810Authorship 2476614Authorship 24928813Authorship 25161210Authorship 25176810Authorship 25182610Authorship 2519677Authorship 2530806Authorship 2532796Authorship 2533785Authorship 2534481Authorship 2542344Authorship 2551884Authorship 2566835Authorship 2573657Authorship 25740611Authorship 2587139Authorship 2597917Authorship 2613871110405134Bedrosian I, Scheff AM, Mick R, Callans LS, Bucky LP, Spitz FR, Helsabeck C, Elder DE, Alavi A, Fraker DF, Czerniecki BJJournal of nuclear medicine : official publication, Society of Nuclear Medicine99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma. J Nucl Med. 1999 Jul; 40(7):1143-8.J Nucl Med1999-07-01T00:00:00199999mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma.12638587Rabinowitz IThe New England journal of medicineCyclin E in breast cancer. N Engl J Med. 2003 Mar 13; 348(11):1063-4; author reply 1063-4.N Engl J Med2003-03-13T00:00:002003Cyclin E in breast cancer.12879462Bedrosian I, Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR, Callans LS, Buzby GP, Rosato EF, Fraker DL, Czerniecki BJCancerChanges in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003 Aug 01; 98(3):468-73.Cancer2003-08-01T00:00:002003Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging.15007381Bedrosian I, Lu KH, Verschraegen C, Keyomarsi KOncogeneCyclin E deregulation alters the biologic properties of ovarian cancer cells. Oncogene. 2004 Apr 08; 23(15):2648-57.Oncogene2004-04-08T00:00:002004Cyclin E deregulation alters the biologic properties of ovarian cancer cells.15708847Wingate H, Zhang N, McGarhen MJ, Bedrosian I, Harper JW, Keyomarsi KThe Journal of biological chemistryThe tumor-specific hyperactive forms of cyclin E are resistant to inhibition by p21 and p27. J Biol Chem. 2005 Apr 15; 280(15):15148-57.J Biol Chem2005-02-10T00:00:002005The tumor-specific hyperactive forms of cyclin E are resistant to inhibition by p21 and p27.16942642Boughey JC, Ross MI, Babiera GV, Bedrosian I, Feig BW, Hwang RF, Kuerer HM, Hunt KKClinical breast cancerSentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer. 2006 Aug; 7(3):248-53.Clin Breast Cancer2006-08-01T00:00:002006Sentinel lymph node surgery in locally recurrent breast cancer.16955504Boughey JC, Khakpour N, Meric-Bernstam F, Ross MI, Kuerer HM, Singletary SE, Babiera GV, Arun B, Hunt KK, Bedrosian ICancerSelective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer. 2006 Oct 01; 107(7):1440-7.Cancer2006-10-01T00:00:002006Selective use of sentinel lymph node surgery during prophylactic mastectomy.17236970Huang EH, Strom EA, Valero V, Fornage B, Perkins GH, Oh JL, Yu TK, Tereffe W, Woodward WA, Hunt KK, Meric-Bernstam F, Sahin AA, Bedrosian I, Hortobagyi GN, Buchholz TAInternational journal of radiation oncology, biology, physicsLocoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):490-6.Int J Radiat Oncol Biol Phys2007-02-01T00:00:002007Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis.17932905Boughey JC, Cormier JN, Xing Y, Hunt KK, Meric-Bernstam F, Babiera GV, Ross MI, Kuerer HM, Singletary SE, Bedrosian ICancerDecision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer. 2007 Dec 01; 110(11):2542-50.Cancer2007-12-01T00:00:002007Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy.19107593Shaye A, Sahin A, Hao Q, Hunt K, Keyomarsi K, Bedrosian IBreast cancer research and treatmentCyclin E deregulation is an early event in the development of breast cancer. Breast Cancer Res Treat. 2009 Jun; 115(3):651-9.Breast Cancer Res Treat2008-12-24T00:00:002008Cyclin E deregulation is an early event in the development of breast cancer.19172584Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, Hwang RF, Kuerer HM, Yang W, Hunt KKCancerPredictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer. 2009 Mar 01; 115(5):962-71.Cancer2009-03-01T00:00:002009Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.19195040Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian ICancerA prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer. 2009 Apr 01; 115(7):1555-62.Cancer2009-04-01T00:00:002009A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.19280264Boughey JC, Wagner J, Garrett BJ, Harker L, Middleton LP, Babiera GV, Meric-Bernstam F, Lucci A, Hunt KK, Bedrosian IAnnals of surgical oncologyNeoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation. Ann Surg Oncol. 2009 Jun; 16(6):1606-11.Ann Surg Oncol2009-03-12T00:00:002009Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation.19362281Wagner J, Boughey JC, Garrett B, Babiera G, Kuerer H, Meric-Bernstam F, Singletary E, Hunt KK, Middleton LP, Bedrosian IAmerican journal of surgeryMargin assessment after neoadjuvant chemotherapy in invasive lobular cancer. Am J Surg. 2009 Sep; 198(3):387-91.Am J Surg2009-04-10T00:00:002009Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer.19427625Boughey JC, Goravanchi F, Parris RN, Kee SS, Kowalski AM, Frenzel JC, Bedrosian I, Meric-Bernstam F, Hunt KK, Ames FC, Kuerer HM, Lucci AAmerican journal of surgeryProspective randomized trial of paravertebral block for patients undergoing breast cancer surgery. Am J Surg. 2009 Nov; 198(5):720-5.Am J Surg2009-05-09T00:00:002009Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery.19730235Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, Meric-Bernstam FAnnals of surgerySentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg. 2009 Oct; 250(4):558-66.Ann Surg2009-10-01T00:00:002009Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients.19735388Fearmonti RM, Batista LI, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Eva Singletary S, Babiera GVThe breast journalFalse negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden. Breast J. 2009 Nov-Dec; 15(6):645-8.Breast J2009-09-07T00:00:002009False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden.20336790Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam FCancerA phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer. 2010 Jun 01; 116(11):2543-8.Cancer2010-06-01T00:00:002010A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.21209588Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI, Kuerer HM, Luo S, Gonzalez-Angulo AM, Buzdar AU, Symmans WF, Feig BW, Lucci A, Huang EH, Hunt KKAnnals of surgeryClassification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg. 2011 Mar; 253(3):572-9.Ann Surg2011-03-01T00:00:002011Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.22253459Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyEvaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol. 2012 Feb 20; 30(6):600-7.J Clin Oncol2012-01-17T00:00:002012Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.22621306Dominici LS, Mittendorf EA, Wang X, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera GV, Buchholz TA, Meric-Bernstam F, Bedrosian IBreast cancer research : BCRImplications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res. 2012 May 23; 14(3):R82.Breast Cancer Res2012-05-23T00:00:002012Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy.22677156Lucci A, Hall CS, Lodhi AK, Bhattacharyya A, Anderson AE, Xiao L, Bedrosian I, Kuerer HM, Krishnamurthy SThe Lancet. OncologyCirculating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol. 2012 Jul; 13(7):688-95.Lancet Oncol2012-06-06T00:00:002012Circulating tumour cells in non-metastatic breast cancer: a prospective study.22895267Duan X, Sneige N, Gullett AE, Prieto VG, Resetkova E, Andino LM, Wu Y, Gilcrease MZ, Bedrosian I, Dawood S, Arun B, Albarracin CTThe American journal of surgical pathologyInvasive paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast. Am J Surg Pathol. 2012 Sep; 36(9):1353-8.Am J Surg Pathol2012-09-01T00:00:002012Invasive paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast.23291658Mittendorf EA, Buchholz TA, Tucker SL, Meric-Bernstam F, Kuerer HM, Gonzalez-Angulo AM, Bedrosian I, Babiera GV, Hoffman K, Yi M, Ross MI, Hortobagyi GN, Hunt KKAnnals of surgeryImpact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy. Ann Surg. 2013 Feb; 257(2):173-9.Ann Surg2013-02-01T00:00:002013Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy.23975313Fitzsullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black DM, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HMAnnals of surgical oncologyIncidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted? Ann Surg Oncol. 2013 Dec; 20(13):4103-12.Ann Surg Oncol2013-08-23T00:00:002013Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?26000884Bhardwaj A, Ganesan N, Tachibana K, Rajapakshe K, Albarracin CT, Gunaratne PH, Coarfa C, Bedrosian IPloS oneAnnexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling. PLoS One. 2015; 10(5):e0127678.PLoS One2015-05-22T00:00:002015Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling.Authorship 2650362Authorship 2651911Authorship 2654261Authorship 2659302Authorship 2688339Authorship 2690121Authorship 2690667Authorship 2697822Authorship 271738210761787Faries MB, Bedrosian I, Reynolds C, Nguyen HQ, Alavi A, Czerniecki BJAnnals of surgical oncologyActive macromolecule uptake by lymph node antigen-presenting cells: a novel mechanism in determining sentinel lymph node status. Ann Surg Oncol. 2000 Mar; 7(2):98-105.Ann Surg Oncol2000-03-01T00:00:002000Active macromolecule uptake by lymph node antigen-presenting cells: a novel mechanism in determining sentinel lymph node status.10819365Bedrosian I, Faries MB, Guerry D, Elenitsas R, Schuchter L, Mick R, Spitz FR, Bucky LP, Alavi A, Elder DE, Fraker DL, Czerniecki BJAnnals of surgical oncologyIncidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase. Ann Surg Oncol. 2000 May; 7(4):262-7.Ann Surg Oncol2000-05-01T00:00:002000Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase.10861431Bedrosian I, Reynolds C, Mick R, Callans LS, Grant CS, Donohue JH, Farley DR, Heller R, Conant E, Orel SG, Lawton T, Fraker DL, Czerniecki BJCancerAccuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer. 2000 Jun 01; 88(11):2540-5.Cancer2000-06-01T00:00:002000Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors.12963845Wingate H, Bedrosian I, Akli S, Keyomarsi KCell cycle (Georgetown, Tex.)The low molecular weight (LMW) isoforms of cyclin E deregulate the cell cycle of mammary epithelial cells. Cell Cycle. 2003 Sep-Oct; 2(5):461-6.Cell Cycle2003-09-01T00:00:002003The low molecular weight (LMW) isoforms of cyclin E deregulate the cell cycle of mammary epithelial cells.16861913Le XF, Bedrosian I, Mao W, Murray M, Lu Z, Keyomarsi K, Lee MH, Zhao J, Bast RCCell cycle (Georgetown, Tex.)Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway. Cell Cycle. 2006 Aug; 5(15):1654-61.Cell Cycle2006-08-01T00:00:002006Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway.18804333Reed VK, Woodward WA, Zhang L, Strom EA, Perkins GH, Tereffe W, Oh JL, Yu TK, Bedrosian I, Whitman GJ, Buchholz TA, Dong LInternational journal of radiation oncology, biology, physicsAutomatic segmentation of whole breast using atlas approach and deformable image registration. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1493-500.Int J Radiat Oncol Biol Phys2008-09-17T00:00:002008Automatic segmentation of whole breast using atlas approach and deformable image registration.20185801Bedrosian I, Hu CY, Chang GJJournal of the National Cancer InstitutePopulation-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010 Mar 17; 102(6):401-9.J Natl Cancer Inst2010-02-25T00:00:002010Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.20853047Kang T, Yi M, Hunt KK, Mittendorf EA, Babiera GV, Kuerer H, Bedrosian I, Hwang RF, Lucci A, Meric-Bernstam FAnnals of surgical oncologyDoes blue dye contribute to success of sentinel node mapping for breast cancer? Ann Surg Oncol. 2010 Oct; 17 Suppl 3:280-5.Ann Surg Oncol2010-09-19T00:00:002010Does blue dye contribute to success of sentinel node mapping for breast cancer?22517269Brewster AM, Bedrosian I, Parker PA, Dong W, Peterson SK, Cantor SB, Crosby M, Shen YCancerAssociation between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer. 2012 Nov 15; 118(22):5637-43.Cancer2012-04-19T00:00:002012Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.Authorship 2735935Authorship 2743105Authorship 2746007Authorship 2748488Authorship 2750957Authorship 275411618357493Rao R, Feng L, Kuerer HM, Singletary SE, Bedrosian I, Hunt KK, Ross MI, Hortobagyi GN, Feig BW, Ames FC, Babiera GVAnnals of surgical oncologyTiming of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol. 2008 Jun; 15(6):1696-702.Ann Surg Oncol2008-03-21T00:00:002008Timing of surgical intervention for the intact primary in stage IV breast cancer patients.21717428Hall C, Krishnamurthy S, Lodhi A, Bhattacharyya A, Anderson A, Kuerer H, Bedrosian I, Singh B, Lucci ACancerDisseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer. Cancer. 2012 Jan 15; 118(2):342-8.Cancer2011-06-29T00:00:002011Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer.21861223Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EAAnnals of surgical oncologyEvaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol. 2012 Mar; 19(3):901-7.Ann Surg Oncol2011-08-23T00:00:002011Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy.22648744Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam FCancerImpact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. Cancer. 2012 Dec 15; 118(24):6287-96.Cancer2012-05-30T00:00:002012Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer.23306905Lang JE, Tereffe W, Mitchell MP, Rao R, Feng L, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Hortobagyi GN, Babiera GVAnnals of surgical oncologyPrimary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Ann Surg Oncol. 2013 Jun; 20(6):1893-9.Ann Surg Oncol2013-01-11T00:00:002013Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival.24258799Advani PS, Ying J, Theriault R, Melhem-Bertrand A, Moulder S, Bedrosian I, Tereffe W, Black S, Pini TM, Brewster AMCancerEthnic disparities in adherence to breast cancer survivorship surveillance care. Cancer. 2014 Mar 15; 120(6):894-900.Cancer2013-11-20T00:00:002013Ethnic disparities in adherence to breast cancer survivorship surveillance care.Authorship 2788398Authorship 2792653Authorship 27930812Authorship 2886607Authorship 2892772Authorship 2893936Authorship 2894648Authorship 2895106Authorship 28980113Authorship 28990610Authorship 2908801Authorship 2915626Authorship 2926306Authorship 2942687Authorship 2949772Authorship 2974142Authorship 29774720Authorship 2986982Authorship 2988567Authorship 3032331Authorship 3047211Authorship 305533824562447Yi M, Huo L, Koenig KB, Mittendorf EA, Meric-Bernstam F, Kuerer HM, Bedrosian I, Buzdar AU, Symmans WF, Crow JR, Bender M, Shah RR, Hortobagyi GN, Hunt KKAnnals of oncology : official journal of the European Society for Medical OncologyWhich threshold for ER positivity? a retrospective study based on 9639 patients. Ann Oncol. 2014 May; 25(5):1004-11.Ann Oncol2014-02-20T00:00:002014Which threshold for ER positivity? a retrospective study based on 9639 patients.24752612Mittendorf EA, Bedrosian IAnnals of surgical oncologyBreast cancer biology: implications for local-regional therapy. Ann Surg Oncol. 2014 Sep; 21(9):2820-2.Ann Surg Oncol2014-04-22T00:00:002014Breast cancer biology: implications for local-regional therapy.24809301Deshmukh AA, Cantor SB, Crosby MA, Dong W, Shen Y, Bedrosian I, Peterson SK, Parker PA, Brewster AMAnnals of surgical oncologyCost of contralateral prophylactic mastectomy. Ann Surg Oncol. 2014 Sep; 21(9):2823-30.Ann Surg Oncol2014-05-09T00:00:002014Cost of contralateral prophylactic mastectomy.24811059Bhardwaj A, Rosen D, Liu M, Liu Y, Hao Q, Ganesan N, Etzel CJ, Gullett A, Albarracin CT, Bedrosian IPloS oneSuppression of Akt-mTOR pathway-a novel component of oncogene induced DNA damage response barrier in breast tumorigenesis. PLoS One. 2014; 9(5):e97076.PLoS One2014-05-08T00:00:002014Suppression of Akt-mTOR pathway-a novel component of oncogene induced DNA damage response barrier in breast tumorigenesis.24841348Mittendorf EA, Caudle AS, Yang W, Krishnamurthy S, Shaitelman S, Chavez-MacGregor M, Woodward WA, Bedrosian I, Kuerer HM, Hunt KKAnnals of surgical oncologyImplementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy? Ann Surg Oncol. 2014 Aug; 21(8):2468-73.Ann Surg Oncol2014-05-20T00:00:002014Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?24859939Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK, Mittendorf EAAnnals of surgical oncologyPredicting the extent of nodal disease in early-stage breast cancer. Ann Surg Oncol. 2014 Oct; 21(11):3440-7.Ann Surg Oncol2014-05-24T00:00:002014Predicting the extent of nodal disease in early-stage breast cancer.24895461Meric-Bernstam F, Akcakanat A, Chen H, Sahin A, Tarco E, Carkaci S, Adrada BE, Singh G, Do KA, Garces ZM, Mittendorf E, Babiera G, Bedrosian I, Hwang R, Krishnamurthy S, Symmans WF, Gonzalez-Angulo AM, Mills GBClinical cancer research : an official journal of the American Association for Cancer ResearchInfluence of biospecimen variables on proteomic biomarkers in breast cancer. Clin Cancer Res. 2014 Jul 15; 20(14):3870-83.Clin Cancer Res2014-06-03T00:00:002014Influence of biospecimen variables on proteomic biomarkers in breast cancer.25047481Bedrosian I, Yao KAnnals of surgical oncologyContralateral prophylactic mastectomy and survival: an ongoing challenge. Ann Surg Oncol. 2014 Oct; 21(11):3372-4.Ann Surg Oncol2014-07-22T00:00:002014Contralateral prophylactic mastectomy and survival: an ongoing challenge.25164970Karhade M, Hall C, Mishra P, Anderson A, Kuerer H, Bedrosian I, Krishnamurthy S, Lucci ABreast cancer research and treatmentCirculating tumor cells in non-metastatic triple-negative breast cancer. Breast Cancer Res Treat. 2014 Sep; 147(2):325-33.Breast Cancer Res Treat2014-08-28T00:00:002014Circulating tumor cells in non-metastatic triple-negative breast cancer.25488970Mittendorf EA, Ballman KV, McCall LM, Yi M, Sahin AA, Bedrosian I, Hansen N, Gabram S, Hurd T, Giuliano AE, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyEvaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer. J Clin Oncol. 2015 Apr 01; 33(10):1119-27.J Clin Oncol2014-12-08T00:00:002014Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer.25822675Parker PA, Peterson SK, Bedrosian I, Crosby MA, Shen Y, Black DM, Babiera G, Kuerer HM, Ying J, Dong W, Cantor SB, Brewster AMAnnals of surgeryProspective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer. Ann Surg. 2016 Jan; 263(1):178-83.Ann Surg2016-01-01T00:00:002016Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.25905585Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KKAnnals of surgical oncologyIs Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ? Ann Surg Oncol. 2015 Dec; 22(13):4270-9.Ann Surg Oncol2015-04-24T00:00:002015Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?25920918Bedrosian I, Yao KAnnals of surgical oncologyContralateral Prophylactic Mastectomy: Anxiety, Knowledge and Shared Decision Making. Ann Surg Oncol. 2015 Nov; 22(12):3767-8.Ann Surg Oncol2015-04-29T00:00:002015Contralateral Prophylactic Mastectomy: Anxiety, Knowledge and Shared Decision Making.26083835Lautner M, Lin H, Shen Y, Parker C, Kuerer H, Shaitelman S, Babiera G, Bedrosian IJAMA surgeryDisparities in the Use of Breast-Conserving Therapy Among Patients With Early-Stage Breast Cancer. JAMA Surg. 2015 Aug; 150(8):778-86.JAMA Surg2015-08-01T00:00:002015Disparities in the Use of Breast-Conserving Therapy Among Patients With Early-Stage Breast Cancer.26156655Bedrosian I, Xing Y, Abdel Rahman S, Allen L, Le-Petross H, Whitman GJ, Meric-Bernstam F, Hunt KK, Babiera GV, Cormier JNAnnals of surgical oncologyA Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer. Ann Surg Oncol. 2016 Jan; 23(1):23-9.Ann Surg Oncol2015-07-09T00:00:002015A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer.26259752Angelos P, Bedrosian I, Euhus DM, Herrmann VM, Katz SJ, Pusic AAnnals of surgical oncologyContralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon. Ann Surg Oncol. 2015 Oct; 22(10):3208-12.Ann Surg Oncol2015-08-11T00:00:002015Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon.26280679Sanford RA, Song J, Gutierrez-Barrera AM, Profato J, Woodson A, Litton JK, Bedrosian I, Albarracin CT, Valero V, Arun BCancerHigh incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors. Cancer. 2015 Oct 01; 121(19):3422-7.Cancer2015-08-17T00:00:002015High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.26282647Mittendorf EA, Bedrosian I, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyReply to L. Antolini et al. J Clin Oncol. 2015 Nov 20; 33(33):3978-9.J Clin Oncol2015-08-17T00:00:002015Reply to L. Antolini et al.26325287McAuliffe PF, Evans KW, Akcakanat A, Chen K, Zheng X, Zhao H, Eterovic AK, Sangai T, Holder AM, Sharma C, Chen H, Do KA, Tarco E, Gagea M, Naff KA, Sahin A, Multani AS, Black DM, Mittendorf EA, Bedrosian I, Mills GB, Gonzalez-Angulo AM, Meric-Bernstam FPloS oneAbility to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. PLoS One. 2015; 10(9):e0136851.PLoS One2015-09-01T00:00:002015Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.74Professor10Assistant Professor14Associate ProfessorBreast Surgical Oncology26511263Swisher SK, Vila J, Tucker SL, Bedrosian I, Shaitelman SF, Litton JK, Smith BD, Caudle AS, Kuerer HM, Mittendorf EAAnnals of surgical oncologyLocoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy. Ann Surg Oncol. 2016 Mar; 23(3):749-56.Ann Surg Oncol2015-10-28T00:00:002015Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.26811528Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HMJournal of clinical oncology : official journal of the American Society of Clinical OncologyImproved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol. 2016 Apr 01; 34(10):1072-8.J Clin Oncol2016-01-25T00:00:002016Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.27406093Carter SA, Lyons GR, Kuerer HM, Bassett RL, Oates S, Thompson A, Caudle AS, Mittendorf EA, Bedrosian I, Lucci A, DeSnyder SM, Babiera G, Yi M, Baumann DP, Clemens MW, Garvey PB, Hunt KK, Hwang RFAnnals of surgical oncologyOperative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction. Ann Surg Oncol. 2016 10; 23(10):3190-8.Ann Surg Oncol2016-07-12T00:00:002016Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction.20443145Sharma R, Bedrosian I, Lucci A, Hwang RF, Rourke LL, Qiao W, Buchholz TA, Kronowitz SJ, Krishnamurthy S, Babiera GV, Gonzalez-Angulo AM, Meric-Bernstam F, Mittendorf EA, Hunt KK, Kuerer HMAnnals of surgical oncologyPresent-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy. Ann Surg Oncol. 2010 Nov; 17(11):2899-908.Ann Surg Oncol2010-05-05T00:00:002010Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.16116079Eder AM, Sui X, Rosen DG, Nolden LK, Cheng KW, Lahad JP, Kango-Singh M, Lu KH, Warneke CL, Atkinson EN, Bedrosian I, Keyomarsi K, Kuo WL, Gray JW, Yin JC, Liu J, Halder G, Mills GBProceedings of the National Academy of Sciences of the United States of AmericaAtypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci U S A. 2005 Aug 30; 102(35):12519-24.Proc Natl Acad Sci U S A2005-08-22T00:00:002005Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.22772869Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KKAnnals of surgical oncologyThe role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol. 2012 Oct; 19(10):3177-84.Ann Surg Oncol2012-07-07T00:00:002012The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer.28160548Bhardwaj A, Singh H, Rajapakshe K, Tachibana K, Ganesan N, Pan Y, Gunaratne PH, Coarfa C, Bedrosian IOncotargetRegulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer. Oncotarget. 2017 Mar 21; 8(12):19645-19660.Oncotarget2017-03-21T00:00:002017Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer.Authorship 842886Authorship 844063Authorship 846193Authorship 846542Authorship 847493Authorship 847619Authorship 848122Authorship 848148Authorship 849884Authorship 850958Authorship 851396Authorship 851632Authorship 852447Authorship 853693Authorship 854283Authorship 855543Authorship 856283Authorship 859218Authorship 860310Authorship 860912Authorship 861852Authorship 862174Authorship 862464Authorship 863950Authorship 865057Authorship 865302Authorship 865628Authorship 865766Authorship 866771Authorship 866862Authorship 867406Authorship 868096Annals of Surgical OncologyPredicting the Extent of Nodal Disease in Early-Stage Breast Cancer. Annals of Surgical Oncology. Predicting the Extent of Nodal Disease in Early-Stage Breast CancerBreast Diseases4-1 Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node-Negative Breast Cancer Patients. Breast Diseases. 17:332-333.4-1 Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node-Negative Breast Cancer PatientsBreast DiseasesAssociation of cyclin D1 genotype with breast cancer risk and survival. Breast Diseases. 16:251-252.Association of cyclin D1 genotype with breast cancer risk and survivalJournal of Clinical OncologyReply to K.J. Van Zee et al. Journal of Clinical Oncology. 30:3144-3145.Reply to K.J. Van Zee et alBreast DiseasesLong-term follow-up study of a prospective multicenter sentinel node trial. Breast Diseases. 22:392-393.Long-term follow-up study of a prospective multicenter sentinel node trialBreast cancer. 479-507.Breast cancerCurrent Breast Cancer ReportsImpact of breast cancer subtypes on local-regional outcomes. Current Breast Cancer Reports. 2:107-113.Impact of breast cancer subtypes on local-regional outcomesAnnals of Surgical OncologyOperative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer. Annals of Surgical Oncology. 1-9.Operative and Oncologic Outcomes in 9861 Patients with Operable Breast CancerBreast DiseasesTissue microarray analyses of GI/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin DI is associated with local recurrence. Breast Diseases. 15:313-314.Tissue microarray analyses of GI/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin DI is associated with local recurrenceAnnals of Surgical OncologyIncidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy. Annals of Surgical Oncology. 23:722-728.Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core BiopsyJournal of Clinical OncologyIn reply. Journal of Clinical Oncology. 27:641-642.In replyAnnals of Surgical OncologyA Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer. Annals of Surgical Oncology. A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular CancerBreast DiseasesChanges in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Breast Diseases. 15:292-293.Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imagingAnnals of Surgical OncologyLocoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy. Annals of Surgical Oncology. 23:749-756.Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving TherapyBreast Cancer ResearchOutcomes of contralateral prophylactic mastectomy in relation to familial history. Breast Cancer Research. 18.Outcomes of contralateral prophylactic mastectomy in relation to familial historyAnnals of Surgical OncologyLong-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal Hyperplasia. Annals of Surgical Oncology. 1-7.Long-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal HyperplasiaAnnals of SurgeryProspective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer. Annals of Surgery. Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast CancerAnnals of Surgical OncologyOutcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Annals of Surgical Oncology. 1-8.Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary TherapyPLoS OneAbility to generate patient-derived Breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes. PLoS One. 10.Ability to generate patient-derived Breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomesInternational Journal of Radiation Oncology Biology PhysicsDisparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast Cancer. International Journal of Radiation Oncology Biology Physics. Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast CancerClinical RadiologySurveillance of women with a personal history of breast cancer by tumour subtype. Clinical Radiology. Surveillance of women with a personal history of breast cancer by tumour subtypeCurrent Breast Cancer ReportsCurrent Multidisciplinary Management of High-Risk Breast Lesions. Current Breast Cancer Reports. 7:81-89.Current Multidisciplinary Management of High-Risk Breast LesionsJournal of the National Cancer InstituteResponse. Journal of the National Cancer Institute. 102:1372-1373.ResponsePLoS OneErratum. PLoS One. 11.ErratumAnnals of Surgical OncologyContralateral Prophylactic Mastectomy. Annals of Surgical Oncology. 22:3208-3212.Contralateral Prophylactic MastectomyPLoS OneAnnexin A1 preferentially predicts poor prognosis of basal-like breast cancer patients by activating mTOR-S6 signaling. PLoS One. 10.Annexin A1 preferentially predicts poor prognosis of basal-like breast cancer patients by activating mTOR-S6 signalingJournal of Clinical OncologyImproved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes. Journal of Clinical Oncology. 34:1072-1078.Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodesBreast DiseasesThe prognostic implication of the basal-like (cyclin E<sup>high</sup>/ p27<sup>low</sup>/p53<sup>+</sup>glomeruloid-microvascular-proliferation <sup>+</sup>) phenotype of BRCA1-related breast cancer. Breast Diseases. 15:387-388.The prognostic implication of the basal-like (cyclin E<sup>high</sup>/ p27<sup>low</sup>/p53<sup>+</sup>glomeruloid-microvascular-proliferation <sup>+</sup>) phenotype of BRCA1-related breast cancerJournal of Comparative Effectiveness ResearchBreast conserving therapy or mastectomy. Journal of Comparative Effectiveness Research. 4:187-189.Breast conserving therapy or mastectomyAnnals of Surgical OncologyImpact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy. Annals of Surgical Oncology. 1-9.Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic MastectomyBreast Diseases2-24 Pathologic Correlates of False Positive Breast Magnetic Resonance Imaging Findings. Breast Diseases. 17:158.2-24 Pathologic Correlates of False Positive Breast Magnetic Resonance Imaging FindingsInternational Journal of Women's HealthContralateral prophylactic mastectomy. International Journal of Women's Health. 8:213-223.Contralateral prophylactic mastectomy14597440Bedrosian I, Bedi D, Kuerer HM, Fornage BD, Harker L, Ross MI, Ames FC, Krishnamurthy S, Edeiken-Monroe BS, Meric F, Feig BW, Akins J, Singletary SE, Mirza NQ, Hunt KKAnnals of surgical oncologyImpact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol. 2003 Nov; 10(9):1025-30.Ann Surg Oncol2003-11-01T00:00:002003Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer.17000390Boughey JC, Bedrosian I, Meric-Bernstam F, Ross MI, Kuerer HM, Akins JS, Giordano SH, Babiera GV, Ames FC, Hunt KKJournal of the American College of SurgeonsComparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg. 2006 Oct; 203(4):475-80.J Am Coll Surg2006-08-23T00:00:002006Comparative analysis of sentinel lymph node operation in male and female breast cancer patients.17826073Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KKAmerican journal of surgeryLong-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg. 2007 Oct; 194(4):527-31.Am J Surg2007-10-01T00:00:002007Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy.22491672Peng G, Dai H, Zhang W, Hsieh HJ, Pan MR, Park YY, Tsai RY, Bedrosian I, Lee JS, Ira G, Lin SYCancer researchHuman nuclease/helicase DNA2 alleviates replication stress by promoting DNA end resection. Cancer Res. 2012 Jun 01; 72(11):2802-13.Cancer Res2012-04-09T00:00:002012Human nuclease/helicase DNA2 alleviates replication stress by promoting DNA end resection.Authorship 8873594Authorship 8881289Authorship 8893049Authorship 8894507D015412Procedures16610250.646965Mastectomy, SegmentalD018275Disorders1696100.727727Carcinoma, LobularD001943Disorders1432156510.17611Breast NeoplasmsD008408Procedures24915140.606664MastectomyD002285Disorders1936730.683271Carcinoma, Intraductal, NoninfiltratingAuthorship 9039305Authorship 9059823Authorship 9068023Authorship 90810810Authorship 9092655Authorship 9100971Authorship 91088120Authorship 9113653Authorship 9116914Authorship 9123834Authorship 9126688Authorship 9134008Authorship 9138429Authorship 9143086Authorship 91515310Authorship 9157863Authorship 9169603Authorship 9191773Authorship 9207911Authorship 9211172Authorship 9215113Authorship 9242257Authorship 92610111Authorship 9267822Authorship 9290515Authorship 9301777Authorship 9321994Authorship 9357393Authorship 9370335Authorship 9383841Authorship 938641625959556Bedrosian I, Shen YJournal of comparative effectiveness researchBreast conserving therapy or mastectomy: a done deal or one worth returning to? J Comp Eff Res. 2015 May; 4(3):187-189.J Comp Eff Res2015-05-11T00:00:002015Breast conserving therapy or mastectomy: a done deal or one worth returning to?26542585Nakhlis F, Gilmore L, Gelman R, Bedrosian I, Ludwig K, Hwang ES, Willey S, Hudis C, Iglehart JD, Lawler E, Ryabin NY, Golshan M, Schnitt SJ, King TAAnnals of surgical oncologyIncidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020). Ann Surg Oncol. 2016 Mar; 23(3):722-8.Ann Surg Oncol2015-11-05T00:00:002015Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).26606424Yao K, Belkora J, Sisco M, Rosenberg S, Bedrosian I, Liederbach E, Wang CJAMA surgerySurvey of the Deficits in Surgeons' Knowledge of Contralateral Prophylactic Mastectomy. JAMA Surg. 2016 Apr; 151(4):391-3.JAMA Surg2016-04-01T00:00:002016Survey of the Deficits in Surgeons' Knowledge of Contralateral Prophylactic Mastectomy.26953790McAuliffe PF, Evans KW, Akcakanat A, Chen K, Zheng X, Zhao H, Eterovic AK, Sangai T, Holder AM, Sharma C, Chen H, Do KA, Tarco E, Gagea M, Naff KA, Sahin A, Multani AS, Black DM, Mittendorf EA, Bedrosian I, Mills GB, Gonzalez-Angulo AM, Meric-Bernstam FPloS oneCorrection: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. PLoS One. 2016; 11(3):e0151121.PLoS One2016-03-08T00:00:002016Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.26853342Shaitelman SF, Lin HY, Smith BD, Shen Y, Bedrosian I, Marsh GD, Bloom ES, Vicini FA, Buchholz TA, Babiera GVInternational journal of radiation oncology, biology, physicsPractical Implications of the Publication of Consensus Guidelines by the American Society for Radiation Oncology: Accelerated Partial Breast Irradiation and the National Cancer Data Base. Int J Radiat Oncol Biol Phys. 2016 Feb 01; 94(2):338-48.Int J Radiat Oncol Biol Phys2015-10-31T00:00:002015Practical Implications of the Publication of Consensus Guidelines by the American Society for Radiation Oncology: Accelerated Partial Breast Irradiation and the National Cancer Data Base.27382334Yao K, Sisco M, Bedrosian IInternational journal of women's healthContralateral prophylactic mastectomy: current perspectives. Int J Womens Health. 2016; 8:213-23.Int J Womens Health2016-06-22T00:00:002016Contralateral prophylactic mastectomy: current perspectives.27209502Loveland-Jones C, Lin H, Shen Y, Bedrosian I, Shaitelman S, Kuerer H, Woodward W, Ueno N, Valero V, Babiera GInternational journal of radiation oncology, biology, physicsDisparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast?Cancer. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1218-25.Int J Radiat Oncol Biol Phys2016-03-10T00:00:002016Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast?Cancer.27573525Menen RS, Ganesan N, Bevers T, Ying J, Coyne R, Lane D, Albarracin C, Bedrosian IAnnals of surgical oncologyLong-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal Hyperplasia. Ann Surg Oncol. 2017 Jan; 24(1):70-76.Ann Surg Oncol2016-08-29T00:00:002016Long-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal Hyperplasia.27650678Davies KR, Brewster AM, Bedrosian I, Parker PA, Crosby MA, Peterson SK, Shen Y, Volk RJ, Cantor SBBreast cancer research : BCROutcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033). Breast Cancer Res. 2016 09 20; 18(1):93.Breast Cancer Res2016-09-20T00:00:002016Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).27654108Yao K, Belkora J, Bedrosian I, Rosenberg S, Sisco M, Barrera E, Kyrillios A, Tilburt J, Wang C, Rabbitt S, Pesce C, Simovic S, Winchester DJ, Sepucha KAnnals of surgical oncologyImpact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study. Ann Surg Oncol. 2017 Jan; 24(1):91-99.Ann Surg Oncol2016-09-21T00:00:002016Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study.27822630FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK, Babiera GV, Caudle AS, Black DM, Bedrosian I, Reyna C, Teshome M, Meric-Bernstam F, Hwang RAnnals of surgical oncologyOutcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Ann Surg Oncol. 2017 Mar; 24(3):652-659.Ann Surg Oncol2016-10-03T00:00:002016Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy.28135395Raghavendra A, Sinha AK, Le-Petross HT, Garg N, Hsu L, Patangan M, Bevers TB, Shen Y, Banu A, Tripathy D, Bedrosian I, Barcenas CHCancerMammographic breast density is associated with the development of contralateral breast cancer. Cancer. 2017 06 01; 123(11):1935-1940.Cancer2017-01-30T00:00:002017Mammographic breast density is associated with the development of contralateral breast cancer.28295213Lin HY, Bedrosian I, Babiera GV, Shaitelman SF, Kuerer HM, Woodward WA, Ueno NT, Shen YCancerUsing the National Cancer Data Base for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer. Cancer. 2017 Jul 15; 123(14):2618-2625.Cancer2017-03-13T00:00:002017Using the National Cancer Data Base for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer.28608612Akay CL, Albarracin C, Torstenson T, Bassett R, Mittendorf EA, Yi M, Kuerer HM, Babiera GV, Bedrosian I, Hunt KK, Hwang RFThe breast journalFactors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer. Breast J. 2018 01; 24(1):28-34.Breast J2017-06-13T00:00:002017Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer.28349337Yao K, Belkora J, Bedrosian I, Rosenberg S, Sisco M, Barrera E, Kyrillos A, Tilburt J, Wang C, Rabbitt S, Pesce C, Simovic S, Winchester DJ, Sepucha KAnnals of surgical oncologyErratum to: Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study. Ann Surg Oncol. 2017 12; 24(Suppl 3):687.Ann Surg Oncol2017-12-01T00:00:002017Erratum to: Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study.28341031Benveniste AP, Dryden MJ, Bedrosian I, Morrow PK, Bassett RL, Yang WClinical radiologySurveillance of women with a personal history of breast cancer by tumour subtype. Clin Radiol. 2017 Mar; 72(3):266.e1-266.e6.Clin Radiol2016-10-27T00:00:002016Surveillance of women with a personal history of breast cancer by tumour subtype.28173790Mitchell KB, Lin H, Shen Y, Colfry A, Kuerer H, Shaitelman SF, Babiera GV, Bedrosian IBMC surgeryDCIS and axillary nodal evaluation: compliance with national guidelines. BMC Surg. 2017 Feb 07; 17(1):12.BMC Surg2017-02-07T00:00:002017DCIS and axillary nodal evaluation: compliance with national guidelines.29114595Moreno AC, Lin YH, Bedrosian I, Shen Y, Stauder MC, Smith BD, Buchholz TA, Babiera GV, Woodward WA, Shaitelman SFAdvances in radiation oncologyUse of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):291-300.Adv Radiat Oncol2017-05-03T00:00:002017Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis.28766207Caudle AS, Bedrosian I, Milton DR, DeSnyder SM, Kuerer HM, Hunt KK, Mittendorf EAAnnals of surgical oncologyUse of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members. Ann Surg Oncol. 2017 Oct; 24(10):2925-2934.Ann Surg Oncol2017-08-01T00:00:002017Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members.29100726Weiss A, Mittendorf EA, DeSnyder SM, Hwang RF, Bea V, Bedrosian I, Hoffman K, Adrade B, Sahin AA, Kuerer HM, Hunt KK, Caudle ASClinical breast cancerExpanding Implementation of ACOSOG Z0011 in Surgeon Practice. Clin Breast Cancer. 2018 08; 18(4):276-281.Clin Breast Cancer2017-10-13T00:00:002017Expanding Implementation of ACOSOG Z0011 in Surgeon Practice.29622133Raber B, Bea VJ, Bedrosian IMagnetic resonance imaging clinics of North AmericaHow Does MR Imaging Help Care for My Breast Cancer Patient? Perspective of a Surgical Oncologist. Magn Reson Imaging Clin N Am. 2018 May; 26(2):281-288.Magn Reson Imaging Clin N Am2018-02-21T00:00:002018How Does MR Imaging Help Care for My Breast Cancer Patient? Perspective of a Surgical Oncologist.29460033Weiss A, Menen RS, Lin HY, Shen Y, Rosso KJ, Shaitelman S, Woodward W, Valero V, Ueno NT, Bedrosian I, Babiera GBreast cancer research and treatmentFactors associated with improved outcomes for metastatic inflammatory breast cancer patients. Breast Cancer Res Treat. 2018 Jun; 169(3):615-623.Breast Cancer Res Treat2018-02-19T00:00:002018Factors associated with improved outcomes for metastatic inflammatory breast cancer patients.29733510Elsayegh N, Webster RD, Gutierrez Barrera AM, Lin H, Kuerer HM, Litton JK, Bedrosian I, Arun BKCancer medicineContralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer. Cancer Med. 2018 06; 7(6):2718-2726.Cancer Med2018-05-07T00:00:002018Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.29796872Bedrosian IAnnals of surgical oncologyScreening Mammography: Getting to Version 2.0. Ann Surg Oncol. 2018 Sep; 25(9):2500-2501.Ann Surg Oncol2018-05-23T00:00:002018Screening Mammography: Getting to Version 2.0.30109538Weiss A, Chu CK, Lin H, Shen Y, Shaitelman SF, Garvey PB, Bedrosian I, Babiera GVAnnals of surgical oncologyReconstruction in the Metastatic Breast Cancer Patient: Results from the National Cancer Database. Ann Surg Oncol. 2018 Oct; 25(11):3125-3133.Ann Surg Oncol2018-08-14T00:00:002018Reconstruction in the Metastatic Breast Cancer Patient: Results from the National Cancer Database.29947001Tevis SE, Neuman HB, Mittendorf EA, Kuerer HM, Bedrosian I, DeSnyder SM, Thompson AM, Black DM, Scoggins ME, Sahin AA, Hunt KK, Caudle ASAnnals of surgical oncologyMultidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins. Ann Surg Oncol. 2018 Oct; 25(10):2932-2938.Ann Surg Oncol2018-06-26T00:00:002018Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins.30645775Bedrosian I, Parker PA, Brewster AMCancerWho should get a contralateral prophylactic mastectomy for breast cancer? Cancer. 2019 05 01; 125(9):1400-1403.Cancer2019-01-15T00:00:002019Who should get a contralateral prophylactic mastectomy for breast cancer?30556120Tevis SE, Bassett R, Bedrosian I, Barcenas CH, Black DM, Caudle AS, DeSnyder SM, Fitzsullivan E, Hunt KK, Kuerer HM, Lucci A, Meric-Bernstam F, Mittendorf EA, Park K, Teshome M, Thompson AM, Hwang RFAnnals of surgical oncologyOncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients. Ann Surg Oncol. 2019 Mar; 26(3):815-820.Ann Surg Oncol2018-12-17T00:00:002018OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients.30561744D'Agostino TA, Brewster AM, Peterson SK, Bedrosian I, Parker PATranslational behavioral medicineDiscussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis. Transl Behav Med. 2020 05 20; 10(2):347-354.Transl Behav Med2020-05-20T00:00:002020Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.30562149DeSnyder SM, Kheirkhah P, Travis ML, Lilly SE, Bedrosian I, Buchholz TA, Schaverien MV, Shaitelman SFLymphatic research and biologyOptimizing Patient Positioning to Reduce Variation in the Measurement of Breast Cancer-Related Lymphedema. Lymphat Res Biol. 2019 08; 17(4):440-446.Lymphat Res Biol2018-12-18T00:00:002018Optimizing Patient Positioning to Reduce Variation in the Measurement of Breast Cancer-Related Lymphedema.30537987Bhardwaj A, Singh H, Trinidad CM, Albarracin CT, Hunt KK, Bedrosian IBreast cancer research : BCRThe isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer. Breast Cancer Res. 2018 12 11; 20(1):150.Breast Cancer Res2018-12-11T00:00:002018The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer.Authorship 9416383Authorship 942292430125673Stecklein SR, Shaitelman SF, Babiera GV, Bedrosian I, Black DM, Ballo MT, Arzu I, Strom EA, Reed VK, Dvorak T, Smith BD, Woodward WA, Hoffman KE, Schlembach PJ, Kirsner SM, Nelson CL, Yang J, Guerra W, Dibaj S, Bloom ESPractical radiation oncologyProspective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy. Pract Radiat Oncol. 2019 Jan; 9(1):e4-e13.Pract Radiat Oncol2018-08-17T00:00:002018Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy.30798445Wood ME, Cuke M, Bedrosian IAnnals of surgical oncologyPrevention Therapy for Breast Cancer: How Can We Do Better? Ann Surg Oncol. 2019 Jul; 26(7):1970-1972.Ann Surg Oncol2019-02-23T00:00:002019Prevention Therapy for Breast Cancer: How Can We Do Better?Authorship 9435914Authorship 944051830044695Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM, Nelson JC, DeSnyder SM, Cook RL, Hunt KK, Volk RJ, Cantor SB, Dong W, Brewster AMJournal of clinical oncology : official journal of the American Society of Clinical OncologyProspective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer. J Clin Oncol. 2018 09 01; 36(25):2630-2638.J Clin Oncol2018-07-25T00:00:002018Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer.30737785Park KU, Kyrish K, Terrell J, Yi M, Caudle AS, Hunt KK, Kuerer HM, Bedrosian I, Thompson A, DeSnyder SM, other members of Department of Breast Surgical Oncology Study GroupJournal of surgical oncologySurgeon perception versus reality: Opioid use after breast cancer surgery. J Surg Oncol. 2019 Jun; 119(7):909-915.J Surg Oncol2019-02-08T00:00:002019Surgeon perception versus reality: Opioid use after breast cancer surgery.Authorship 945780431025270Weiss A, Lin H, Babiera GV, Bedrosian I, Shaitelman SF, Shen Y, Kuerer HM, Mittendorf EA, Caudle AS, Hunt KK, Hwang RFBreast cancer research and treatmentEvolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes. Breast Cancer Res Treat. 2019 Jul; 176(2):435-444.Breast Cancer Res Treat2019-04-25T00:00:002019Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes.Authorship 947138431099648Carter S, Neuman H, Mamounas EP, Bedrosian I, Moulder S, Montero AJ, Jagsi RAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual MeetingDebating the Optimal Approach to Nodal Management After Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer. Am Soc Clin Oncol Educ Book. 2019 Jan; 39:42-48.Am Soc Clin Oncol Educ Book2019-05-17T00:00:002019Debating the Optimal Approach to Nodal Management After Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.Authorship 951810531280501Wood ME, Garber JE, Isaacs C, Masood S, Bedrosian I, Tung N, Chun J, Schnabel FR, Arun BK, International Society of Cancer Risk Assessment and ManagementThe breast journalGenetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations. Breast J. 2019 07; 25(4):575-577.Breast J2019-07-01T00:00:002019Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.Authorship 953265331377160Buszek SM, Lin HY, Bedrosian I, Tamirisa N, Babiera GV, Shen Y, Shaitelman SFInternational journal of radiation oncology, biology, physicsLumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor-Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database. Int J Radiat Oncol Biol Phys. 2019 11 15; 105(4):795-802.Int J Radiat Oncol Biol Phys2019-08-01T00:00:002019Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor-Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database.Authorship 957066531605340Raber BM, Lin H, Shen Y, Shaitelman SF, Bedrosian IAnnals of surgical oncologyTrends in Regional Nodal Management of Breast Cancer Patients with Low Nodal Burden. Ann Surg Oncol. 2019 Dec; 26(13):4346-4354.Ann Surg Oncol2019-10-11T00:00:002019Trends in Regional Nodal Management of Breast Cancer Patients with Low Nodal Burden.Authorship 958133331667721Yi M, Lin H, Bedrosian I, Shen Y, Hunt KK, Chavez-MacGregor M, King TA, Mittendorf EAAnnals of surgical oncologyStaging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors. Ann Surg Oncol. 2020 Feb; 27(2):359-366.Ann Surg Oncol2019-10-30T00:00:002019Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors.Authorship 962354431820211Park KU, Kyrish K, Yi M, Bedrosian I, Caudle AS, Kuerer HM, Hunt KK, Miggins MV, DeSnyder SMAnnals of surgical oncologyOpioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use. Ann Surg Oncol. 2020 Mar; 27(3):730-735.Ann Surg Oncol2019-12-09T00:00:002019Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use.Authorship 974563331865627Wood ME, Rehman HT, Bedrosian IThe breast journalImportance of family history and indications for genetic testing. Breast J. 2020 01; 26(1):100-104.Breast J2019-12-22T00:00:002019Importance of family history and indications for genetic testing.Authorship 977840332047541Moreno AC, Lin YH, Bedrosian I, Shen Y, Babiera GV, Shaitelman SFJournal of CancerOutcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes. J Cancer. 2020; 11(6):1341-1350.J Cancer2020-01-01T00:00:002020Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes.Authorship 979713532125937Hwang ES, Hyslop T, Hendrix LH, Duong S, Bedrosian I, Price E, Caudle A, Hieken T, Guenther J, Hudis CA, Winer E, Lyss AP, Dickson-Witmer D, Hoefer R, Ollila DW, Hardman T, Marks J, Chen YY, Krings G, Esserman L, Hylton NJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance). J Clin Oncol. 2020 04 20; 38(12):1284-1292.J Clin Oncol2020-03-03T00:00:002020Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance).Authorship 980211632204397Ju Z, Bhardwaj A, Embury MD, Singh H, Gunaratne PH, Bedrosian I, Wang JCancersIntegrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title: Molecular Landscape of Basal-Like Breast Cancer Progression). Cancers (Basel). 2020 Mar 19; 12(3).Cancers (Basel)2020-03-19T00:00:002020Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title: Molecular Landscape of Basal-Like Breast Cancer Progression).Authorship 986375532243226Tung NM, Boughey JC, Pierce LJ, Robson ME, Bedrosian I, Dietz JR, Dragun A, Gelpi JB, Hofstatter EW, Isaacs CJ, Jatoi I, Kennedy E, Litton JK, Mayr NA, Qamar RD, Trombetta MG, Harvey BE, Somerfield MR, Zakalik DJournal of clinical oncology : official journal of the American Society of Clinical OncologyManagement of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline. J Clin Oncol. 2020 06 20; 38(18):2080-2106.J Clin Oncol2020-04-03T00:00:002020Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.Authorship 989991332442068Kuhl CK, Lehman C, Bedrosian IJournal of clinical oncology : official journal of the American Society of Clinical OncologyImaging in Locoregional Management of Breast Cancer. J Clin Oncol. 2020 07 10; 38(20):2351-2361.J Clin Oncol2020-05-22T00:00:002020Imaging in Locoregional Management of Breast Cancer.Authorship 993142832613237Lau R, Du L, Chen E, Fu C, Gould R, Marczyk M, Sinn BV, Layman R, Bedrosian I, Valero V, Symmans WFClinical chemistryTechnical Validity of a Customized Assay of Sensitivity to Endocrine Therapy Using Sections from Fixed Breast Cancer Tissue. Clin Chem. 2020 07 01; 66(7):934-945.Clin Chem2020-07-01T00:00:002020Technical Validity of a Customized Assay of Sensitivity to Endocrine Therapy Using Sections from Fixed Breast Cancer Tissue.Authorship 994493832672820Tamirisa N, Lin H, Shen Y, Shaitelman SF, Sri Karuturi M, Giordano SH, Babiera G, Bedrosian IJAMA oncologyAssociation of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor-Positive, Node-Positive Breast Cancer. JAMA Oncol. 2020 10 01; 6(10):1548-1554.JAMA Oncol2020-10-01T00:00:002020Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor-Positive, Node-Positive Breast Cancer.Authorship 9952136Authorship 9954542Authorship 995536532710271Postlewait LM, Teshome M, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Woodward WA, Ueno NT, Lucci AAnnals of surgical oncologyFactors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery? Ann Surg Oncol. 2020 Nov; 27(12):4603-4612.Ann Surg Oncol2020-07-24T00:00:002020Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?32712892Murphy BL, Bedrosian IAnnals of surgical oncologyASO Author Reflections: Performance of Contralateral Risk-Reducing Mastectomy in Multigene Panel-Tested Patients is High in All Types of Germline Mutation Carriers. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):678-679.Ann Surg Oncol2020-07-25T00:00:002020ASO Author Reflections: Performance of Contralateral Risk-Reducing Mastectomy in Multigene Panel-Tested Patients is High in All Types of Germline Mutation Carriers.32720048Murphy BL, Yi M, Arun BK, Gutierrez Barrera AM, Bedrosian IAnnals of surgical oncologyContralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing. Ann Surg Oncol. 2020 Nov; 27(12):4613-4621.Ann Surg Oncol2020-07-27T00:00:002020Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.Authorship 1002853733056990Napoli M, Li X, Ackerman HD, Deshpande AA, Barannikov I, Pisegna MA, Bedrosian I, Mitsch J, Quinlan P, Thompson A, Rajapakshe K, Coarfa C, Gunaratne PH, Marchion DC, Magliocco AM, Tsai KY, Flores ERNature communicationsPan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation. Nat Commun. 2020 10 14; 11(1):5156.Nat Commun2020-10-14T00:00:002020Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation.Authorship 1003348633092312Ju Z, Bhardwaj A, Embury MD, Singh H, Gunaratne PH, Bedrosian I, Wang JCancersErratum: Ju, Z., et al. Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That Is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title: Molecular Landscape of Basal-Like Breast Cancer Progression). Cancers 2020, 12, 722. Cancers (Basel). 2020 Oct 20; 12(10).Cancers (Basel)2020-10-20T00:00:002020Erratum: Ju, Z., et al. Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That Is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title: Molecular Landscape of Basal-Like Breast Cancer Progression). Cancers 2020, 12, 722.Authorship 1008487933417121Simons JM, Scoggins ME, Kuerer HM, Krishnamurthy S, Yang WT, Sahin AA, Shen Y, Lin H, Bedrosian I, Mittendorf EA, Thompson A, Lane DL, Hunt KK, Caudle ASAnnals of surgical oncologyProspective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients. Ann Surg Oncol. 2021 Aug; 28(8):4277-4283.Ann Surg Oncol2021-01-08T00:00:002021Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients.Authorship 1010431933528758Yang L, Roy M, Lin H, Shen Y, Albarracin C, Huo L, Chen H, Wei B, Bedrosian I, Bu H, Wu YBreast cancer research and treatmentValidation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast. Breast Cancer Res Treat. 2021 Apr; 186(2):403-415.Breast Cancer Res Treat2021-02-02T00:00:002021Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast.Authorship 1012139733617937Du L, Yau C, Brown-Swigart L, Gould R, Krings G, Hirst GL, Bedrosian I, Layman RM, Carter JM, Klein M, Venters S, Shad S, van der Noordaa M, Chien AJ, Haddad T, Isaacs C, Pusztai L, Albain K, Nanda R, Tripathy D, Liu MC, Boughey J, Schwab R, Hylton N, DeMichele A, Perlmutter J, Yee D, Berry D, Van't Veer L, Valero V, Esserman LJ, Symmans WFAnnals of oncology : official journal of the European Society for Medical OncologyPredicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy. Ann Oncol. 2021 05; 32(5):642-651.Ann Oncol2021-02-19T00:00:002021Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy.Authorship 1014022833735487Tamirisa N, Lin H, Shen Y, Shaitelman SF, Karuturi MS, Giordano SH, Babiera GV, Bedrosian ICancerImpact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-A National Cancer Database analysis. Cancer. 2021 07 01; 127(13):2196-2203.Cancer2021-03-18T00:00:002021Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-A National Cancer Database analysis.Authorship 1015897933813685McLemore LE, Albarracin CT, Gruschkus SK, Bassett RL, Wu Y, Dhamne S, Yim I, Lin K, Bedrosian I, Sneige N, Chen HBreast cancer research and treatmentHER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines. Breast Cancer Res Treat. 2021 May; 187(1):95-104.Breast Cancer Res Treat2021-04-03T00:00:002021HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines.Authorship 10162651533849913Wood ME, Liu H, Storrick E, Zahrieh D, Le-Petross HC, Jung SH, Zekan P, Kemeny MM, Charlamb JR, Wang LX, Unzeitig GW, Johnson CS, Garber JE, Marshall JR, Bedrosian ICancer prevention research (Philadelphia, Pa.)The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial. Cancer Prev Res (Phila). 2021 07; 14(7):753-762.Cancer Prev Res (Phila)2021-04-13T00:00:002021The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial.Authorship 1016944533893908Bhardwaj A, Embury MD, Rojo RD, Albarracin C, Bedrosian IBreast cancer research and treatmentEfficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer. Breast Cancer Res Treat. 2021 Jun; 187(2):363-374.Breast Cancer Res Treat2021-04-24T00:00:002021Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer.Authorship 1017251833914469Kilgore LJ, Yi M, Bevers T, Coyne R, Marita L, Lane D, Albarracin C, Bedrosian IAnnals of surgeryRisk of Breast Cancer in Selected Women With Atypical Ductal Hyperplasia Who do not Undergo Surgical Excision. Ann Surg. 2022 Dec 01; 276(6):e932-e936.Ann Surg2021-03-04T00:00:002021Risk of Breast Cancer in Selected Women With Atypical Ductal Hyperplasia Who do not Undergo Surgical Excision.Authorship 1017551433938495Smith-Graziani DJ, Parker PA, Peterson SK, Bedrosian I, Shen Y, Black DM, DeSnyder SM, Hunt KK, Dong W, Brewster AMAnnals of surgeryProspective Study of Pain Outcomes Associated With Breast Surgery in Women With Nonhereditary Breast Cancer. Ann Surg. 2023 03 01; 277(3):e617-e623.Ann Surg2021-04-30T00:00:002021Prospective Study of Pain Outcomes Associated With Breast Surgery in Women With Nonhereditary Breast Cancer.Authorship 1019041934017965Singh P, Scoggins ME, Sahin AA, Hwang RF, Kuerer HM, Caudle AS, Mittendorf EA, Thompson AM, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt KKAnnals of surgery open : perspectives of surgical history, education, and clinical approachesEffectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial. Ann Surg Open. 2020 Dec; 1(2).Ann Surg Open2020-12-01T00:00:002020Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial.Authorship 1021149734125346Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci AAnnals of surgical oncologyContralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. 2021 Dec; 28(13):8610-8621.Ann Surg Oncol2021-06-14T00:00:002021Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer.Authorship 1024518234226566Boyce-Fappiano D, Bedrosian I, Shen Y, Lin H, Gjyshi O, Yoder A, Shaitelman SF, Woodward WANPJ breast cancerEvaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis. NPJ Breast Cancer. 2021 Jul 05; 7(1):87.NPJ Breast Cancer2021-07-05T00:00:002021Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis.Authorship 1026513234328640Kilgore LJ, Murphy BL, Postlewait LM, Liang DH, Bedrosian I, Lucci A, Kuerer HM, Hunt KK, Teshome MJournal of surgical oncologyImpact of the early COVID-19 pandemic on Breast Surgical Oncology fellow education. J Surg Oncol. 2021 Dec; 124(7):989-994.J Surg Oncol2021-07-30T00:00:002021Impact of the early COVID-19 pandemic on Breast Surgical Oncology fellow education.Authorship 103070310Authorship 10310701034582940Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SFInternational journal of radiation oncology, biology, physicsBreast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing. Int J Radiat Oncol Biol Phys. 2022 02 01; 112(2):437-444.Int J Radiat Oncol Biol Phys2021-09-25T00:00:002021Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing.34610390Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SFInternational journal of radiation oncology, biology, physicsOutcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation. Int J Radiat Oncol Biol Phys. 2022 02 01; 112(2):426-436.Int J Radiat Oncol Biol Phys2021-10-03T00:00:002021Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation.Authorship 10384455Authorship 1038546335296281Bhardwaj A, Embury MD, Ju Z, Wang J, Bedrosian IBMC cancerGene signature associated with resistance to fluvastatin chemoprevention for breast cancer. BMC Cancer. 2022 Mar 17; 22(1):282.BMC Cancer2022-03-17T00:00:002022Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer.35303253Makhnoon S, Arun B, Bedrosian ICurrent oncology reportsHelping Patients Understand and Cope with BRCA Mutations. Curr Oncol Rep. 2022 06; 24(6):733-740.Curr Oncol Rep2022-03-18T00:00:002022Helping Patients Understand and Cope with BRCA Mutations.14746836Bedrosian I, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane C, Janjan N, Skibber JMJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractPredicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg. 2004 Jan; 8(1):56-62; discussion 62-3.J Gastrointest Surg2004-01-01T00:00:002004Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma.16392024Bedrosian I, Giacco G, Pederson L, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane CH, Janjan N, Skibber JMDiseases of the colon and rectumOutcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum. 2006 Feb; 49(2):175-82.Dis Colon Rectum2006-02-01T00:00:002006Outcome after curative resection for locally recurrent rectal cancer.Authorship 1047071635653124Suman VJ, Du L, Hoskin T, Anurag M, Ma C, Bedrosian I, Hunt KK, Ellis MJ, Symmans WFClinical cancer research : an official journal of the American Association for Cancer ResearchEvaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031). Clin Cancer Res. 2022 08 02; 28(15):3287-3295.Clin Cancer Res2022-08-02T00:00:002022Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031).Authorship 1051013735869155Bhardwaj A, Rojo RD, Ju Z, Koh A, Tachibana K, Wang J, Bedrosian IScientific reportsThe molecular heterogeneity of the precancerous breast affects drug efficacy. Sci Rep. 2022 07 22; 12(1):12590.Sci Rep2022-07-22T00:00:002022The molecular heterogeneity of the precancerous breast affects drug efficacy.Authorship 10577918Authorship 10603907Authorship 1057716536199482Elmore LC, Li M, Lin H, Shen Y, Shaitelman SF, Babiera G, Tamirisa N, Bedrosian IAnnals of surgery open : perspectives of surgical history, education, and clinical approachesImpact of Medicaid Expansion Under the Affordable Care Act on Receipt of Surgery for Breast Cancer. Ann Surg Open. 2022 Sep; 3(3):e194.Ann Surg Open2022-08-24T00:00:002022Impact of Medicaid Expansion Under the Affordable Care Act on Receipt of Surgery for Breast Cancer.36685664Makhnoon S, Gutierrez Barrera AM, Bassett R, Afrough A, Bedrosian I, Arun BKThe breast journalContralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences. Breast J. 2022; 2022:1447545.Breast J2022-12-31T00:00:002022Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences.36332081Asaad M, Mitchell D, Murphy B, Liu J, Selber JC, Clemens MW, Bedrosian I, Butler CEPlastic and reconstructive surgerySurgical Outcomes of Implant versus Autologous Breast Reconstruction in Patients with Previous Breast-Conserving Surgery and Radiotherapy. Plast Reconstr Surg. 2023 02 01; 151(2):190e-199e.Plast Reconstr Surg2022-11-08T00:00:002022Surgical Outcomes of Implant versus Autologous Breast Reconstruction in Patients with Previous Breast-Conserving Surgery and Radiotherapy.Authorship 1063517636741254Shen Y, Ning J, Lin HY, Shaitelman SF, Kuerer HM, Bedrosian IJournal of CancerEffectiveness Without Efficacy: Cautionary Tale from a Landmark Breast Cancer Randomized Controlled Trial. J Cancer. 2023; 14(2):193-199.J Cancer2023-01-01T00:00:002023Effectiveness Without Efficacy: Cautionary Tale from a Landmark Breast Cancer Randomized Controlled Trial.Authorship 10647742036863241Gandhi A, Xu T, DeSnyder SM, Smith GL, Lin R, Barcenas CH, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Garner D, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I, Shaitelman SFBreast (Edinburgh, Scotland)Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast. 2023 Apr; 68:205-215.Breast2023-02-24T00:00:002023Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program.Authorship 10660931836951827Serrano D, Gandini S, Thomas P, Crew KD, Kumar NB, Vornik LA, Lee JJ, Veronesi P, Viale G, Guerrieri-Gonzaga A, Lazzeroni M, Johansson H, D'Amico M, Guasone F, Spinaci S, Bertelsen BE, Mellgren G, Bedrosian I, Weber D, Castile T, Dimond E, Heckman-Stoddard BM, Szabo E, Brown PH, DeCensi A, Bonanni BJAMA oncologyEfficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial. JAMA Oncol. 2023 05 01; 9(5):664-672.JAMA Oncol2023-05-01T00:00:002023Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.Authorship 10684363Authorship 1068820937071025Pan IW, Yen TWF, Bedrosian I, Shih YTJCO oncology practiceCurrent Trends in the Utilization of Preoperative Breast Magnetic Resonance Imaging Among Women With Newly Diagnosed Breast Cancer. JCO Oncol Pract. 2023 07; 19(7):446-455.JCO Oncol Pract2023-04-17T00:00:002023Current Trends in the Utilization of Preoperative Breast Magnetic Resonance Imaging Among Women With Newly Diagnosed Breast Cancer.37046802Li H, Robinson K, Lan L, Baughan N, Chan CW, Embury M, Whitman GJ, El-Zein R, Bedrosian I, Giger MLCancersTemporal Machine Learning Analysis of Prior Mammograms for Breast Cancer Risk Prediction. Cancers (Basel). 2023 Apr 04; 15(7).Cancers (Basel)2023-04-04T00:00:002023Temporal Machine Learning Analysis of Prior Mammograms for Breast Cancer Risk Prediction.Authorship 10735577Authorship 107200230Authorship 1072640837259799O'Shea AE, Clifton GT, Qiao N, Heckman-Stoddard BM, Wojtowicz M, Dimond E, Bedrosian I, Weber D, Garber JE, Husband A, Pastorello R, Lee JJ, Hernandez M, Liu DD, Vornik LA, Brown PH, Alatrash G, Peoples GE, Mittendorf EACancer prevention research (Philadelphia, Pa.)Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ. Cancer Prev Res (Phila). 2023 06 01; 16(6):333-341.Cancer Prev Res (Phila)2023-06-01T00:00:002023Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.37450351Hermida-Prado F, Xie Y, Sherman S, Nagy Z, Russo D, Akhshi T, Chu Z, Feit A, Campisi M, Chen M, Nardone A, Guarducci C, Lim K, Font-Tello A, Lee I, Garc?a-Pedrero J, Ca?adas I, Agudo J, Huang Y, Sella T, Jin Q, Tayob N, Mittendorf EA, Tolaney SM, Qiu X, Long H, Symmans WF, Lin JR, Santagata S, Bedrosian I, Yardley DA, Mayer IA, Richardson ET, Oliveira G, Wu CJ, Schuster EF, Dowsett M, Welm AL, Barbie D, Metzger O, Jeselsohn RCancer researchEndocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer. Cancer Res. 2023 10 02; 83(19):3284-3304.Cancer Res2023-10-02T00:00:002023Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.37426053Baughan N, Li H, Lan L, Embury M, Yim I, Whitman GJ, El-Zein R, Bedrosian I, Giger MLJournal of medical imaging (Bellingham, Wash.)Radiomic and deep learning characterization of breast parenchyma on full field digital mammograms and specimen radiographs: a pilot study of a potential cancer field effect. J Med Imaging (Bellingham). 2023 Jul; 10(4):044501.J Med Imaging (Bellingham)2023-07-08T00:00:002023Radiomic and deep learning characterization of breast parenchyma on full field digital mammograms and specimen radiographs: a pilot study of a potential cancer field effect.Authorship 10777074Authorship 10777561137670121Farley C, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, Hunt K, Kuerer H, Singh P, Sun S, Tamirisa N, Teshome M, Hwang RFAnnals of surgical oncologyTo Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer? Ann Surg Oncol. 2023 Dec; 30(13):8327-8334.Ann Surg Oncol2023-09-05T00:00:002023To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?37566192Yang L, Lin H, Shen Y, Roy M, Albarracin C, Ding Q, Huo L, Chen H, Wei B, Bu H, Bedrosian I, Wu YBreast cancer research and treatmentClinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study. Breast Cancer Res Treat. 2023 Nov; 202(1):23-32.Breast Cancer Res Treat2023-08-11T00:00:002023Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study.Authorship 10797285Authorship 108000416Authorship 1080035537744342Mistretta B, Rankothgedera S, Castillo M, Rao M, Holloway K, Bhardwaj A, El Noafal M, Albarracin C, El-Zein R, Rezaei H, Su X, Akbani R, Shao XM, Czerniecki BJ, Karchin R, Bedrosian I, Gunaratne PHFrontiers in immunologyChimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer. Front Immunol. 2023; 14:1188831.Front Immunol2023-09-06T00:00:002023Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer.37744722Xie CL, Whitman GJ, Middleton LP, Bevers TB, Bedrosian I, Chung HLJournal of breast imagingIsolated Flat Epithelial Atypia: Upgrade Outcomes After Multidisciplinary Review-Based Management Using Excision or Imaging Surveillance. J Breast Imaging. 2023 Sep-Oct; 5(5):575-584.J Breast Imaging2023-07-22T00:00:002023Isolated Flat Epithelial Atypia: Upgrade Outcomes After Multidisciplinary Review-Based Management Using Excision or Imaging Surveillance.37751078Wang J, Chen H, Koenig J, Wu Y, Bedrosian I, Arun B, Ding Q, Khazai L, Resetkova E, Huo L, Sneige N, Albarracin CBreast cancer research and treatmentDiscordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers. Breast Cancer Res Treat. 2024 Jan; 203(1):73-83.Breast Cancer Res Treat2023-09-26T00:00:002023Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers.Authorship 10849995Authorship 1085584938099455Tamirisa N, Lei X, Malinowski C, Li M, Bedrosian I, Chavez-MacGregor MAnnals of surgeryAssociation of Medicaid Expansion with Reduction in Racial Disparities in the Timely Delivery of up-front Surgical Care for Patients with Early-Stage Breast Cancer. Ann Surg. 2023 Dec 15.Ann Surg2023-12-15T00:00:002023Association of Medicaid Expansion with Reduction in Racial Disparities in the Timely Delivery of up-front Surgical Care for Patients with Early-Stage Breast Cancer.38117388Everidge SA, Sun J, Teshome M, Tamirisa N, Sun S, Adesoye T, Nia E, Bevers T, Bedrosian I, Patel M, Singh PAnnals of surgical oncologyLobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management. Ann Surg Oncol. 2024 Apr; 31(4):2224-2230.Ann Surg Oncol2023-12-20T00:00:002023Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.Authorship 1086221138175972Bedrosian I, Somerfield MR, Achatz MI, Boughey JC, Curigliano G, Friedman S, Kohlmann WK, Kurian AW, Laronga C, Lynce F, Norquist BS, Plichta JK, Rodriguez P, Shah PD, Tischkowitz M, Wood M, Yadav S, Yao K, Robson MEJournal of clinical oncology : official journal of the American Society of Clinical OncologyGermline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. J Clin Oncol. 2024 Feb 10; 42(5):584-604.J Clin Oncol2024-01-04T00:00:002024Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.Authorship 1087622238252903Kurian AW, Bedrosian I, Kohlmann WK, Somerfield MR, Robson MEJCO oncology practiceGermline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline Q and A. JCO Oncol Pract. 2024 Jan 22; OP2300771.JCO Oncol Pract2024-01-22T00:00:002024Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline Q and A.true1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor24736987Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Munsell MF, Chemaly RF, Graviss LS, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GVAnnals of surgical oncologyTiming of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation. Ann Surg Oncol. 2014 Aug; 21(8):2512-6.Ann Surg Oncol2014-04-16T00:00:002014Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation.